Latest news
Phase III Trials Show Positive Results for Ritlecitinib in Nonsegmental Vitiligo - Medical DialoguesMedical Dialogues · Sun, 02 Aug 2026 23:30:18 GMTPfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filings - Indian Pharma PostIndian Pharma Post · Sat, 01 Aug 2026 14:24:34 GMTRitlecitinib Hits Primary Goals in Phase 3 Vitiligo Studies - The Dermatology DigestThe Dermatology Digest · Thu, 30 Jul 2026 17:59:11 GMTPfizer's ritlecitinib advances to become first oral systemic therapy for nonsegmental vitiligo - AllSciAllSci · Thu, 30 Jul 2026 16:35:55 GMTRitlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials - Dermatology TimesDermatology Times · Thu, 30 Jul 2026 13:32:39 GMTPfizer's oral drug restores skin pigmentation in late-stage vitiligo trials - ReutersReuters · Thu, 30 Jul 2026 07:00:00 GMTPfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo - Business WireBusiness Wire · Thu, 30 Jul 2026 07:00:00 GMTPfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMT